Methylation patterns in whole blood correlate with symptoms in Schizophrenia patients

Schizophrenia Bulletin

Volumn 40, Issue 4, 2014, Pages 769-776

  Liu, Jingyu ^a,b   Chen, Jiayu ^a,b   Ehrlich, Stefan ^c,d   Walton, Esther ^c,d   White, Tonya ^e   Perrone Bizzozero, Nora ^f   Bustillo, Juan ^g   Turner, Jessica A ^a,g   Calhoun, Vince D ^a,b,f,g  

^a MIND RESEARCH NETWORK   (United States)

^b University of New Mexico   (United States)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d HARVARD MEDICAL SCHOOL   (United States)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

gene expression; hyper or hypomethylation; inflammatory response; reality distortion symptom

Indexed keywords

ALCOHOL; CBFA2T3 PROTEIN; CD244 PROTEIN; CD7 ANTIGEN; FAM173A PROTEIN; LAX1 PROTEIN; NICOTINE; PRF1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; B LYMPHOCYTE ACTIVATION; BLOOD; BLOOD SAMPLING; CANNABIS USE; CELL DIFFERENTIATION; CONTROLLED STUDY; CPG ISLAND; CYTOTOXICITY; DELUSION; DNA METHYLATION; FEMALE; GENDER; GENE EXPRESSION; GRANULOCYTE; HALLUCINATION; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; NEGATIVE SYNDROME; NEUROBIOLOGY; NEUROLOGIC DISEASE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RACE; REALITY DISTORTION SYMPTOM; SCHIZOPHRENIA; T LYMPHOCYTE ACTIVATION; UPREGULATION; ALCOHOLISM; CASE CONTROL STUDY; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; INFLAMMATION; MARIJUANA ABUSE; METABOLISM; PSYCHOLOGY; SMOKING; STATISTICAL MODEL; YOUNG ADULT;

ADULT; ALCOHOLISM; CASE-CONTROL STUDIES; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; LINEAR MODELS; MALE; MARIJUANA ABUSE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SMOKING; YOUNG ADULT;

EID: 84897067259     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbt080     Document Type: Article

References (56)

1. Petronis A. The origin of schizophrenia: genetic thesis, epi-genetic antithesis, and resolving synthesis. Biol Psychiatry. 2004;55:965-970.
2. Haaf T. Methylation dynamics in the early mammalian embryo: implications of genome reprogramming defects for development. Curr Top Microbiol Immunol. 2006;310:13-22.
3. Paulsen M, Ferguson-Smith AC. DNA methylation in genomic imprinting, development, and disease. J Pathol. 2001;195:97-110.
4. Tuck-Muller CM, Narayan A, Tsien F, et al. DNA hypometh-ylation and unusual chromosome instability in cell lines from ICF syndrome patients. Cytogenet Cell Genet. 2000;89:121-128.
5. Thibaut F. Why schizophrenia genetics needs epigenetics: a review. Psychiatr Danub. 2012;24:25-27.
6. Malaspina D, Perrin M, Kleinhaus KR, Opler M, Harlap S. Growth and schizophrenia: aetiology, epidemiology and epi-genetics. Novartis Found Symp. 2008;289:196-203; discussion 203-197, 238-140.
7. Müller N, Dursun SM. Schizophrenia genes, epigenetics and psychoneuroimmunology therapeutics: all make sense now? J Psychopharmacol. 2011;25:713-714.
8. Akbarian S. The molecular pathology of schizophrenia-focus on histone and DNA modifcations. Brain Res Bull. 2010;83:103-107.
9. Maric NP, Svrakic DM. Why schizophrenia genetics needs epigenetics: a review. Psychiatr Danub. 2012;24:2-18.
10. Abdolmaleky HM, Cheng KH, Russo A, et al. Hypermethy-lation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report. Am J Med Genet B Neuropsychiatr Genet. 2005;134B:60-66.
11. Abdolmaleky HM, Cheng KH, Faraone SV, et al. Hypom-ethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet. 2006;15:3132-3145.
12. Grayson DR, Jia X, Chen Y, et al. Reelin promoter hyper-methylation in schizophrenia. Proc Natl Acad Sci U S A. 2005;102:9341-9346.
13. Iwamoto K, Bundo M, Yamada K, et al. DNA methyla-tion status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J Neurosci. 2005;25:5376-5381.
14. Peedicayil J. The role of epigenetics in altered gene expression involved in GABAergic transmission in the cerebellum of schizophrenia patients. Am J Psychiatry. 2009;166:493; author reply 493-494.
15. Mill J, Tang T, Kaminsky Z, et al. Epigenomic profling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet. 2008;82:696-711.
16. Davies MN, Volta M, Pidsley R, et al. Functional annotation of the human brain methylome identifes tissue-specifc epigenetic variation across brain and blood. Genome Biol. 2012;13:R43.
17. Teschendorff AE, Menon U, Gentry-Maharaj A, et al. An epigenetic signature in peripheral blood predicts active ovarian cancer. PLoS One. 2009;4:e8274.
18. Widschwendter M, Apostolidou S, Raum E, et al. Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study. PLoS One. 2008;3:e2656.
19. Hsiung DT, Marsit CJ, Houseman EA, et al. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2007;16:108-114.
20. Nohesara S, Ghadirivasf M, Mostafavi S, et al. DNA hypo-methylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder. J Psychiatr Res. 2011;45:1432-1438.
21. Dempster EL, Pidsley R, Schalkwyk LC, et al. Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Genet. 2011;20:4786-4796.
22. Chen Y, Zhang J, Zhang L, Shen Y, Xu Q. Effects of MAOA promoter methylation on susceptibility to paranoid schizophrenia. Hum Genet. 2012;131:1081-1087.
23. Melas PA, Rogdaki M, Ösby U, Schalling M, Lavebratt C, Ekström TJ. Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset. FASEB J. 2012;26:2712-2718.
24. Shimabukuro M, Sasaki T, Imamura A, et al. Global hypo-methylation of peripheral leukocyte DNA in male patients with schizophrenia: a potential link between epigenetics and schizophrenia. J Psychiatr Res. 2007;41:1042-1046.
25. Cullen KR, Wallace S, Magnotta VA, et al. Cigarette smoking and white matter microstructure in schizophrenia. Psychiatry Res. 2012;201:152-158.
26. Andreasen NC. Scale for the assessment of positive symptoms (SAPS). Iowa City, IA: University of Iowa; 1984.
27. Andreasen NC. Scale for the Assessment of Negative Symptoms (SANS). Iowa City: University of Iowa; 1983.
28. Bocklandt S, Lin W, Sehl ME, et al. Epigenetic predictor of age. PLoS One. 2011;6:e14821.
29. Christensen BC, Houseman EA, Marsit CJ, et al. Aging and environmental exposures alter tissue-specifc DNA meth-ylation dependent upon CpG island context. PLoS Genet. 2009;5:e1000602.
30. Liu J, Morgan M, Hutchison K, Calhoun VD. A study of the infuence of sex on genome wide methylation. PLoS One. 2010;5:e10028.
31. Liu J, Hutchison K, Perrone-Bizzozero N, Morgan M, Sui J, Calhoun V. Identifcation of genetic and epigenetic marks involved in population structure. PLoS One. 2010;5:e13209.
32. Cordero P, Gomez-Uriz AM, Campion J, Milagro FI, Martinez JA. Dietary supplementation with methyl donors reduces fatty liver and modifes the fatty acid synthase DNA methylation profle in rats fed an obesogenic diet. Genes Nutr. 2013;8:105-113.
33. Niculescu MD, Zeisel SH. Diet, methyl donors and DNA methylation: interactions between dietary folate, methionine and choline. J Nutr. 2002;132:2333S-2335S.
34. Lim U, Song MA. Dietary and lifestyle factors of DNA methylation. Methods Mol Biol. 2012;863:359-376.
35. Philibert RA, Gunter TD, Beach SR, Brody GH, Madan A. MAOA methylation is associated with nicotine and alcohol dependence in women. Am J Med Genet B Neuropsychiatr Genet. 2008;147B:565-570.
36. Bleich S, Lenz B, Ziegenbein M, et al. Epigenetic DNA hypermethylation of the HERP gene promoter induces down-regulation of its mRNA expression in patients with alcohol dependence. Alcohol Clin Exp Res. 2006;30:587-591.
37. Chang HW, Ling GS, Wei WI, Yuen AP. Smoking and drinking can induce p15 methylation in the upper aerodigestive tract of healthy individuals and patients with head and neck squamous cell carcinoma. Cancer. 2004;101:125-132.
38. Breitling LP, Salzmann K, Rothenbacher D, Burwinkel B, Brenner H. Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease. Eur Heart J. 2012;33:2841-2848.
39. Wong CC, Mill J, Fernandes C. Drugs and addiction: an introduction to epigenetics. Addiction. 2011;106:480-489.
40. Breitling LP, Yang R, Korn B, Burwinkel B, Brenner H. Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. Am J Hum Genet. 2011;88:450-457.
41. Ehrlich S, Walton E, Roffman JL, et al. Smoking, but not malnutrition, infuences promoter-specifc DNA methylation of the proopiomelanocortin gene in patients with and without anorexia nervosa. Can J Psychiatry. 2012;57:168-176.
42. Philibert RA, Plume JM, Gibbons FX, Brody GH, Beach SR. The impact of recent alcohol use on genome wide DNA methylation signatures. Front Genet. 2012;3:54.
43. Zhou FC, Balaraman Y, Teng M, Liu Y, Singh RP, Nephew KP. Alcohol alters DNA methylation patterns and inhibits neural stem cell differentiation. Alcohol Clin Exp Res. 2011;35:735-746.
44. Ouko LA, Shantikumar K, Knezovich J, Haycock P, Schnugh DJ, Ramsay M. Effect of alcohol consumption on CpG methylation in the differentially methylated regions of H19 and IG-DMR in male gametes: implications for fetal alcohol spectrum disorders. Alcohol Clin Exp Res. 2009;33:1615-1627.
45. Morris CV, DiNieri JA, Szutorisz H, Hurd YL. Molecular mechanisms of maternal cannabis and cigarette use on human neurodevelopment. Eur J Neurosci. 2011;34:1574-1583.
46. Gardner DM, Murphy AL, O'Donnell H, Centorrino F, Baldessarini RJ. International consensus study of antipsy-chotic dosing. Am J Psychiatry. 2010;167:686-693.
47. Doorduin J, de Vries EF, Willemsen AT, de Groot JC, Dierckx RA, Klein HC. Neuroinfammation in schizophrenia-related psychosis: a PET study. J Nucl Med. 2009;50:1801-1807.
48. Kato T, Monji A, Hashioka S, Kanba S. Risperidone signif-cantly inhibits interferon-gamma-induced microglial activation in vitro. Schizophr Res. 2007;92:108-115.
49. Hou Y, Wu CF, Yang J Y, et al. Effects of clozapine, olan-zapine and haloperidol on nitric oxide production by lipopol-ysaccharide-activated N9 cells. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:1523-1528.
50. Müller N, Riedel M, Scheppach C, et al. Benefcial antip-sychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am J Psychiatry. 2002;159:1029-1034.
51. Miyaoka T, Yasukawa R, Yasuda H, Hayashida M, Inagaki T, Horiguchi J. Minocycline as adjunctive therapy for schizophrenia: an open-label study. Clin Neuropharmacol. 2008;31:287-292.
52. Levkovitz Y, Mendlovich S, Riwkes S, et al. A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. J Clin Psychiatry. 2010;71:138-149.
53. Laan W, Grobbee DE, Selten JP, Heijnen CJ, Kahn RS, Burger H. Adjuvant aspirin therapy reduces symptoms of schizophrenia spectrum disorders: results from a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry. 2010;71:520-527.
54. Cornish S, Mehl-Madrona L. The role of vitamins and minerals in psychiatry. Integr Med Insights. 2008;3:33-42.
55. Petrie WM, Ban TA. Vitamins in psychiatry. Do they have a role? Drugs. 1985;30:58-65.
56. Reinius LE, Acevedo N, Joerink M, et al. Differential DNA methylation in purifed human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS One. 2012;7:e41361.